Makoto Kawashima - Concepedia

Author

Makoto Kawashima

Also Known As

Kawashima M, Kawashima Makoto, Kawashima, Makoto, M Kawashima, M Zander, M. KAWASHIMA, M. Kawashima, MAKOTO KAWASHIMA, Makoto KAWASHIMA, Makoto Kawashima

433

Publications

9.8K

Citations

H-Index

168

Concepts

All Affiliations

Tokyo Women's Medical University Kao Corporation (Japan)Toranomon Hospital Kyoto University Maruho (Japan)

About

Makoto Kawashima is an author at Tokyo Women's Medical University specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	67	5.5K
2	Engineering	9	9	365
3	Health Sciences	3	3	99
4	Language Studies	1	1	17
5	Natural Sciences	1	1	27

Makoto Kawashima

147

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Decreased Level of Ceramides in Stratum Corneum of Atopic Dermatitis: An Etiologic Factor in Atopic Dry Skin? Genji Imokawa, Akihito Abe, Kumi Jin, Journal of Investigative Dermatology AllergyAtopic DermatitisStratum CorneumSkin AllergyContact Dermatitis	1991	1K
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial Diamant Thaçi, Eric L. Simpson, Lisa A. Beck, The Lancet AllergyAtopic DermatitisAllergy MedicineModerate-to-severe Atopic DermatitisSkin Allergy	2015	560
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus Kenji Kabashima, Takayo Matsumura, Hiroshi Komazaki, New England Journal of Medicine	2020	339
Decreased Levels of Sphingosine, a Natural Antimicrobial Agent, may be Associated with Vulnerability of the Stratum Corneum from Patients with Atopic Dermatitis to Colonization by Staphylococcus aureus Junko Arikawa, Mutsumi Ishibashi, Makoto Kawashima, Journal of Investigative Dermatology InflammationAtopic DermatitisStratum CorneumImmunologyStaphylococcus Aureus	2002	266
High-Expression of Sphingomyelin Deacylase is an Important Determinant of Ceramide Deficiency Leading to Barrier Disruption in Atopic Dermatitis1 Junko Hara, Kazuhiko Higuchi, Reiko Okamoto, Journal of Investigative Dermatology InflammationAtopic DermatitisAtopic Dermatitis1ImmunologySphingomyelin Deacylase	2000	226
Abnormal Expression of Sphingomyelin Acylase in Atopic Dermatitis: An Etiologic Factor for Ceramide Deficiency? Yasuko Murata, Junko Ogata, Yuko Higaki, Journal of Investigative Dermatology InflammationCeramide DeficiencyAutoimmune DiseaseAllergyAtopic Dermatitis	1996	210
Acquired, bilateral nevus of Ota-like macules Yoshiaki Hori, Makoto Kawashima, Kuniaki Oohara, Journal of the American Academy of Dermatology Surgical PathologyHistopathologyBilateral NevusPathologyOtorhinolaryngology	1984	206
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis Margitta Worm, Eric L. Simpson, Diamant Thaçi, JAMA Dermatology	2019	192
A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia Walter Gubelin Harcha, Julia Barboza Martínez, Tsen‐Fang Tsai, Journal of the American Academy of Dermatology Dutasteride Versus PlaceboMedicinePlacebo-controlled StudyDermatologyPharmacology	2014	163
Establishment of grading criteria for acne severity Nobukazu Hayashi, Hirohiko Akamatsu, Makoto Kawashima The Journal of Dermatology Global SeverityMedicinePatient SafetyDiagnosisClinical Epidemiology	2008	152

Page 1